Sarah Mougalian, MD

Assistant Professor of Medicine (Medical Oncology); Assistant Professor in Medicine (Medical Oncology)

Patient Care

Accepts new patients? Yes
Patient Type: Adult; Geriatric
Referrals: From patients or physicians

Patient Care Organizations

Medical Oncology: Subset Medical Oncology Faculty

Cancer Center: Breast Center at Smilow Cancer Hospital

Yale Medical Group

Board Certifications

  • Internal Medicine AB of Internal Medicine (2009)

  • Medical Oncology AB of Internal Medicine (2013)

Clinical Trials

Conditions Study Title
Breast - Female, Breast - Male Doxorubicin+Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in TNBC Patients
Breast - Female, Breast - Male Neoadjuvant MEDI4736 with nab-paclitaxel followed by ddAC for stage 1-3 TNBC
Breast - Female Randomized study comparing MPDL3280A with Nab-Paclitaxel compared to placebo with Nab-Paclitaxel
Breast - Female, Breast - Male Olaparib as Adjuvant Treatment in Patients With BRCA Mutated High Risk HER2 Negative breast cancer
Breast - Female, Breast - Male MM-302 Plus Trastuzumab vs. Chemotherapy Plus Trastuzumab in HER2-positive MBC
Breast - Female Neoadj ph 2 AI plus everolimus in postmenopausal women w/ ER pos/HER2 neg, low risk score
Breast - Female An Observational Cohort Study of Tx Patterns & Outcomes in Pts w/HER2+ Metastatic Breast Cancer
Breast - Female, Breast - Male Phase II with Orteronel as Monotherapy for Metastatic Breast Cancer that expresses Androgen Receptor
Breast - Female Phase I Study of SGN-LIV1A via IV Infusion in Patients with LIV-1-positive Metastatic Breast Cancer
Breast - Female, Breast - Male S1207 Phase 3 Rand, Adj Endocrine Tx plus Everolimus in High risk ER/PR + HER2neg BC
Breast - Female, Breast - Male THE INFORM: BRCA1/2 STUDY: INVESTIGATION OF NEOADJUVANT CHEMOTHERAPY FOR MUTATION CARRIERS: BRCA1/2
Breast - Female, Breast - Male Phase I with GDC-0032 for Tx of Local Advanced or Metastatic Solid Tumors or HER2+ Breast Cancer
Breast - Female Neo-Adj, Phase 2, Pertuzumab and Trastuzumab with weekly Paclitaxel and FEC, HER2-pos Breast Cancer
Breast - Female, Breast - Male Breast Cancer Molecular Analysis Prior to Investigational Therapy (MAP-IT)

Edit this profile

Contact Info

Sarah Mougalian, MD
Patient Care Location
Yale Cancer CenterYale-New Haven Hospital
20 York Street, Ste North Pavilion 1

New Haven, CT 06510
View on map...
Mailing Address
25 York Street
PO Box 208028

New Haven, CT 06510

Curriculum Vitae